Literature DB >> 11434484

Practice parameter for the assessment and treatment of children and adolescents with schizophrenia. American Academy of Child and Adolescent Psychiatry.

.   

Abstract

This practice parameter reviews the literature on the assessment and treatment of children and adolescents with schizophrenia. Recommendations are based on the limited research available, the adult literature, and clinical experience. Early-onset schizophrenia is diagnosed using the same criteria as in adults, and it appears to be continuous with the adult form of the disorder. Noted characteristics of youth with schizophrenia include predominance in males, high rates of premorbid abnormalities, and often poor outcome. Differential diagnosis includes psychotic mood disorders, developmental disorders, organic conditions, and nonpsychotic emotional/behavioral disorders. Treatment strategies incorporate antipsychotic medications with psychoeducational, psychotherapeutic, and social and educational support programs. The advent of atypical antipsychotic agents has enhanced the potential for effective treatment.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11434484     DOI: 10.1097/00004583-200107001-00002

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  23 in total

1.  A comparison of adolescent- and adult-onset first-episode, non-affective psychosis: 2-year follow-up.

Authors:  Johannes Langeveld; Inge Joa; Svein Friis; Wenche ten Velden Hegelstad; Ingrid Melle; Jan O Johannessen; Stein Opjordsmoen; Erik Simonsen; Per Vaglum; Bjørn Auestad; Thomas McGlashan; Tor K Larsen
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-03-23       Impact factor: 5.270

2.  Hospital-Based Quality Measures for Pediatric Mental Health Care.

Authors:  Naomi S Bardach; Q Burkhart; Laura P Richardson; Carol P Roth; J Michael Murphy; Layla Parast; Courtney A Gidengil; Jordan Marmet; Maria T Britto; Rita Mangione-Smith
Journal:  Pediatrics       Date:  2018-06       Impact factor: 7.124

3.  Psychotic disorders in children and adolescents: a primer on contemporary evaluation and management.

Authors:  Jonathan R Stevens; Jefferson B Prince; Laura M Prager; Theodore A Stern
Journal:  Prim Care Companion CNS Disord       Date:  2014-03-13

4.  Youth mental health in deprived urban areas: a Delphi study on the role of the GP in early intervention.

Authors:  E Schaffalitzky; D Leahy; W Cullen; B Gavin; L Latham; R O'Connor; B P Smyth; E O'Dea; S Ryan
Journal:  Ir J Med Sci       Date:  2014-09-06       Impact factor: 1.568

5.  Outcome of EEGs ordered at a regional children's mental health service.

Authors:  Greta Toni Swart; Aryan Wahab
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2010-05

6.  The relationship between Asperger's syndrome and schizophrenia in adolescence.

Authors:  Petra Waris; Nina Lindberg; Kirsi Kettunen; Pekka Tani
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-10-13       Impact factor: 4.785

7.  Assessing psychotic-like symptoms using the BASC-2: adolescent, parent and teacher agreement.

Authors:  Katie L Nugent; Emily Kline; Elizabeth Thompson; Gloria Reeves; Jason Schiffman
Journal:  Early Interv Psychiatry       Date:  2013-01-24       Impact factor: 2.732

Review 8.  Quality concerns in antipsychotic prescribing for youth: a review of treatment guidelines.

Authors:  Edith Kealey; Sarah Hudson Scholle; Sepheen C Byron; Kimberly Hoagwood; Emily Leckman-Westin; Kelly Kelleher; Molly Finnerty
Journal:  Acad Pediatr       Date:  2014 Sep-Oct       Impact factor: 3.107

9.  Ethnic variation in symptoms and response to risperidone in youths with schizophrenia-spectrum disorders.

Authors:  Nick C Patel; M Lynn Crismon; Alan Shafer; Anthony De Leon; Molly Lopez; Daniel C Lane
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2006-02-08       Impact factor: 4.328

Review 10.  Should cognitive deficit be a diagnostic criterion for schizophrenia?

Authors:  Ralph Lewis
Journal:  J Psychiatry Neurosci       Date:  2004-03       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.